Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization, and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering, and cell processing to produce active cellular immunotherapy (ACI) product candidates designed to stimulate an immune response in a variety of tumor types.

from http://www.dendreon.com/about/

Publications show all

Dendreon has published 39 articles.

Patents show all

181Issued121Applications

Clinical Trials show all

13Phase 25N/A4Phase 32Phase 1

SEC Filings show all

8-K20210-Q4410-K14D1S-11

Contact Information


    Overview

    Total FundingEmployeesLast Funding DateStatus
    Acquired